ION¿
Report
- Report Number
- 2134265-2012-03859
- Event Type
- Injury
- Date Received
- July 2, 2012
- Date of Event
- May 25, 2012
- Report Date
- June 6, 2012
- Manufacturer
- BOSTON SCIENTIFIC - MAPLE GROVE
- Product Code
- NIQ
- PMA / PMN Number
- P100023
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- TN, US
- Reporter Occupation
- PHYSICIAN
Narratives
DEVICE IS COMBINATION PRODUCT. (B)(4). DEVICE EVALUATED BY MFR: IT IS INDICATED THAT THE DEVICE WILL NOT BE RETURNED FOR EVALUATION; THEREFORE, A FAILURE ANALYSIS OF THE COMPLAINT DEVICE COULD NOT BE COMPLETED. A REVIEW OF THE BATCH HISTORY, HISTORICAL TRENDING AND SIMILAR COMPLAINT TRENDING REVIEW FOR THE PRODUCT FAMILY WILL BE CONDUCTED. IF THERE IS ANY FURTHER RELEVANT INFORMATION FROM THAT REVIEW, A SUPPLEMENTAL MEDWATCH WILL BE FILED. (B)(4).
(B)(6) CLINICAL TRIAL. IT WAS REPORTED THAT POST A STENTING TREATMENT PROCEDURE, ANGINA AND IN-STENT RESTENOSIS OCCURRED. (B)(6) 2012 - THE PATIENT PRESENTED WITH STABLE ANGINA. THE 80% STENOSED, 15MM LONG TARGET LESION WAS LOCATED IN THE MID LAD, DISTAL TO THE PREVIOUSLY PLACED STENTS, WITH A REFERENCE VESSEL DIAMETER OF 2.5MM. THE TARGET LESION WAS TREATED WITH PRE-DILATATION AND PLACEMENT OF 2.50 MM X 20 MM ION US COA STENT WITH 0% RESIDUAL STENOSIS. THE SUBJECT WAS DISCHARGED THE NEXT DAY ON CLOPIDOGREL. (B)(6) 2012 - THE PATIENT PRESENTED WITH ANGINA. CORONARY ANGIOGRAPHY REVEALED DIFFUSE IN-STENT RESTENOSIS (ISR) WITH A 99% END-STENT STENOSIS IN THE MID LAD. THE ISR WAS TREATED WITH BALLOON ANGIOPLASTY AND PLACEMENT OF TWO NON-BSC DRUG ELUTING STENTS, 2.5 X 26MM AND 2.5 X 12MM, WITH 10% RESIDUAL STENOSIS. TWO DAYS LATER THE EVENT WAS CONSIDERED RESOLVED WITHOUT ANY RESIDUAL EFFECTS. THE PATIENT WAS ON ASPIRIN AND CLOPIDOGREL AT THE TIME OF THE EVENT.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1 | ION¿ | CORONARY DRUG-ELUTING STENT | NIQ | BOSTON SCIENTIFIC - MAPLE GROVE | H7493902420250 | 14759293 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 66 YR | Hospitalization| R |